TY - JOUR
T1 - The Impact of Combined Risk-Reducing Gynecological Surgeries on Outcomes in DIEP Flap and Tissue-Expander Breast Reconstruction
AU - Jayaraman, Avinash P.
AU - Boyd, Travis
AU - Hampton, Savannah N.
AU - Haddock, Nicholas T.
AU - Teotia, Sumeet S.
N1 - Publisher Copyright:
© 2020 The Author(s).
PY - 2020/5/1
Y1 - 2020/5/1
N2 - Introduction: In addition to prophylactic mastectomies, BRCA1 and BRCA2 mutation carriers are increasingly choosing to undergo risk-reducing procedures such as hysterectomies and salpingo-oophorectomies. Sometimes these surgeries are performed in the same visit as a mastectomy or a revisionary reconstruction procedure. Literature lacks descriptions of complications and trends for these combined surgeries. Methods: Group 1 patients (n = 10, flaps = 20) had abdominal gynecologic procedures at the time of deep inferior epigastric artery perforator flap (DIEP flap) reconstruction. Group 2 patients (n = 29, breasts = 58) had gynecologic procedures at the time of mastectomy and tissue-expander placement. Group 3 patients (n = 141, breasts = 257) had mastectomy and tissue-expander reconstruction without gynecologic procedures and were used as a control group for group 2. Group 4 patients (n = 357, flaps = 673) had autologous breast reconstruction without gynecologic procedures and were used as a control for group 1. Categorical variables such as complications and flap loss were analyzed using χ2 tests. Continuous variables such as age, body mass index (BMI), operative time, length of stay were analyzed with 2-tailed t tests. Multivariate analyses were run to control for group differences. Results: Groups 1 and 4 were equivalent in age and comorbidities, except group 1 (32.8 kg/m2) had significantly higher BMI than group 4 (31.4 kg/m2), P =.028. Average operating time was statistically equivalent for group 1 patients (610 minutes) and group 4 patients (503 minutes), P =.289. Average hospital stay was equivalent as well (group 1 = 4.4 days, group 4 = 4.1 days, P =.676). Operative times for group 2 patients (457 minutes) were significantly longer than for group 3 patients (288 minutes), P <.01. Group 2 patients (3 nights) had significantly longer hospital stays than group 3 patients (2 nights), P <.01. Group 1 patients (2/20 flaps, 10%) had a significantly higher rate of flap loss than group 4 patients (8/673 flaps, 1%), P <.01. There were no differences in other flap complications. Additionally, there were no significant differences in postoperative tissue-expander complications between group 2 and group 3. Discussion: Both flap losses in Group 1 patients occurred in a single patient with BMI = 39.3 kg/m2 and a personal history of recurrent DVTs. Additionally, the rates of complications across other measures were equivalent between groups. Thus, despite the increased rate of flap loss in Group 1 (10%) vs Group 4 (1.3%), along with the increased operative times and hospital stays, certain patients can be advised that a prophylactic gynecological procedure is safe to combine with breast reconstruction.
AB - Introduction: In addition to prophylactic mastectomies, BRCA1 and BRCA2 mutation carriers are increasingly choosing to undergo risk-reducing procedures such as hysterectomies and salpingo-oophorectomies. Sometimes these surgeries are performed in the same visit as a mastectomy or a revisionary reconstruction procedure. Literature lacks descriptions of complications and trends for these combined surgeries. Methods: Group 1 patients (n = 10, flaps = 20) had abdominal gynecologic procedures at the time of deep inferior epigastric artery perforator flap (DIEP flap) reconstruction. Group 2 patients (n = 29, breasts = 58) had gynecologic procedures at the time of mastectomy and tissue-expander placement. Group 3 patients (n = 141, breasts = 257) had mastectomy and tissue-expander reconstruction without gynecologic procedures and were used as a control group for group 2. Group 4 patients (n = 357, flaps = 673) had autologous breast reconstruction without gynecologic procedures and were used as a control for group 1. Categorical variables such as complications and flap loss were analyzed using χ2 tests. Continuous variables such as age, body mass index (BMI), operative time, length of stay were analyzed with 2-tailed t tests. Multivariate analyses were run to control for group differences. Results: Groups 1 and 4 were equivalent in age and comorbidities, except group 1 (32.8 kg/m2) had significantly higher BMI than group 4 (31.4 kg/m2), P =.028. Average operating time was statistically equivalent for group 1 patients (610 minutes) and group 4 patients (503 minutes), P =.289. Average hospital stay was equivalent as well (group 1 = 4.4 days, group 4 = 4.1 days, P =.676). Operative times for group 2 patients (457 minutes) were significantly longer than for group 3 patients (288 minutes), P <.01. Group 2 patients (3 nights) had significantly longer hospital stays than group 3 patients (2 nights), P <.01. Group 1 patients (2/20 flaps, 10%) had a significantly higher rate of flap loss than group 4 patients (8/673 flaps, 1%), P <.01. There were no differences in other flap complications. Additionally, there were no significant differences in postoperative tissue-expander complications between group 2 and group 3. Discussion: Both flap losses in Group 1 patients occurred in a single patient with BMI = 39.3 kg/m2 and a personal history of recurrent DVTs. Additionally, the rates of complications across other measures were equivalent between groups. Thus, despite the increased rate of flap loss in Group 1 (10%) vs Group 4 (1.3%), along with the increased operative times and hospital stays, certain patients can be advised that a prophylactic gynecological procedure is safe to combine with breast reconstruction.
KW - BRCA1
KW - BRCA2
KW - BSO
KW - DIEP flap
KW - TAH
KW - TAH-BSO
KW - breast reconstruction
KW - combined gynecological
KW - prophylactic
KW - tissue expander
UR - http://www.scopus.com/inward/record.url?scp=85084974371&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084974371&partnerID=8YFLogxK
U2 - 10.1177/2292550320925905
DO - 10.1177/2292550320925905
M3 - Article
C2 - 32596186
AN - SCOPUS:85084974371
SN - 2292-5503
VL - 28
SP - 112
EP - 116
JO - Plastic Surgery
JF - Plastic Surgery
IS - 2
ER -